BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2820 related articles for article (PubMed ID: 7736392)

  • 1. Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.
    Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2484-91. PubMed ID: 7736392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
    Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous melanoma. Prognostic classification of anatomic location.
    Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of localized melanoma by the exponential survival trees method.
    Huang X; Soong S; McCarthy WH; Urist MM; Balch CM
    Cancer; 1997 Mar; 79(6):1122-8. PubMed ID: 9070489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.
    Vollmer RT; Seigler HF
    Am J Clin Pathol; 2001 Feb; 115(2):205-12. PubMed ID: 11211608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S; Kamo R; Harada T; Ishii M
    Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
    Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
    Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors of localized malignant melanoma: study of 639 patients].
    Nagore Enguídanos E; Oliver Martínez V; Botella Estrada R; Insa Mollá A; Fortea Baixauli JM
    Med Clin (Barc); 2005 Mar; 124(10):361-7. PubMed ID: 15766505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL; Fine JA; Roush GC; Berwick M
    Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with localized primary cutaneous melanoma.
    Mervic L
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
    Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
    J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
    Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 141.